Clinical Trial Update: Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection [Phase 1]

View source ↗

Summary

Phase I study evaluating the safety and immunogenicity of an HIV-1 immunogen in children with HIV-1 infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIV-1 immunogen

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HIV Infection | Phase 1 | Status: COMPLETED